Denmark’s Novo Nordisk has teamed up with US digital health company Noom on a project that will develop programmes to help people with obesity achieve and maintain weight loss. Noom has developed a weight-loss app and a personalised meal-planning service that it says is already used by more than 45 million people worldwide and helps
To address the lack of online information about diabetes, Novo Nordisk turned to YouTube star Michael Stevens, who runs the Vsauce channel, and collated a mix of marketing strategies that includes influencers, original content, and SEO. Jeremy Shepler, head of U.S. commercialization for Novo Nordisk’s diabetes drug Ozempic, talked about the lessons learned from the
The Danish pharmaceutical company plans to use voice-activated technology such as Amazon’s Alexa to improve diabetes care have taken a step forward. Novo Nordisk have teamed up with HITLAB (Health Innovation Technology Lab) last year to support its 17th health innovation World Cup, which focused for the first time on voice tech in type 2
The digital health deal between Novo Nordisk’s and Glooko produced a new diabetes management app, C4C that they hope will assist users to better manage the condition. The C4C app also includes relevant content and resources from Novo’s Cornerstones4Care personalised support programme. David Moore, senior vice president of marketing at Novo Nordisk, said: “In today’s
Novo Nordisk and Glooko have announced that they will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s deep knowledge of diabetes with Glooko’s digital platform and data expertise. Building upon Glooko’s mobile and web platforms, the companies aim to deliver personalised services
